Oncogenic β-catenin mutations evade pH-regulated degradation.

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Beta-catenin is crucial for cell-cell adhesion and Wnt signaling pathways.
• Intracellular pH (pHi) is a critical cellular parameter influencing protein stability and function.
• Previous research suggests a link between pH and protein regulation, but specific mechanisms involving key signaling molecules like beta-catenin remain underexplored.

Purpose of the Study:

• To investigate the role of intracellular pH (pHi) in regulating beta-catenin protein abundance.
• To elucidate the mechanism by which pHi affects beta-catenin stability, focusing on its interaction with E3 ubiquitin ligases.
• To determine the oncogenic potential of beta-catenin mutations that disrupt pH-dependent regulation.

Main Methods:

• Utilized cell culture models to manipulate intracellular pH (pHi).
• Employed biochemical assays to assess beta-catenin protein levels and its interaction with beta-transducin repeat containing E3 ubiquitin protein ligase (β-TrCP).
• Introduced specific beta-catenin mutations to disrupt the identified pH-sensitive interaction and evaluated tumor formation in vivo.

Main Results:

• Beta-catenin protein abundance significantly decreases at higher intracellular pH (pHi).
• Increased pHi enhances the binding of beta-catenin to the E3 ubiquitin ligase β-TrCP, promoting beta-catenin degradation.
• Mutations in beta-catenin that abolish the pH-sensitive interaction with β-TrCP lead to constitutive stabilization and induce significant tumor formation, unlike other stabilizing mutants.

Conclusions:

• Intracellular pH (pHi) is a critical regulator of beta-catenin protein stability through pH-dependent interaction with β-TrCP.
• The pH-sensitive degradation of beta-catenin by β-TrCP acts as a tumor suppressor mechanism.
• Targeting the pH-dependent regulation of beta-catenin may offer novel therapeutic strategies for cancers driven by beta-catenin stabilization.